Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.

Researchers shared long-term follow-up data from the Colchicine-PCI trial, which compared colchicine administration before PCI with a placebo.

Out of more than 250 abstracts submitted at its annual meeting in Boston, SCCT named one winner and two runners-up. 

COVID-19 opened the eyes of many cardiology researchers that infections may promote inflammation in atherosclerotic plaques, leading to cardiac events.

Creating these complex structures with 3D printing alone has never been possible—until now. 

What’s more, the model proved beneficial in a large, diverse cohort that included women with benign breast disease and BRCA mutations.

Researchers tracked data from nearly 7,000 TAVR patients for two years, focusing on all-cause mortality and heart failure hospitalizations.

Although the predictive power of radiomics has been touted as a tool that could improve patient outcomes, the method has a long way to go before it can be reliably introduced into real-world clinical environments.